NEURANA PHARMACEUTICALS, INC.

Profile

Company Names

NEURANA PHARMACEUTICALS, INC.

Addresses

4370 LA JOLLA VILLAGE DRIVE, SUITE 860, SAN DIEGO, CA 92122

3525 DEL MAR HEIGHTS RD., SUITE 609, SAN DIEGO, CA 92130

Phone Numbers

(858) 732-0702
(858) 756-2480

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$45,707,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2018-05-03 
$41,888,250.00 
$64,888,250.00 
$23,000,000.00 
Equity 
1
2013-12-30 
$3,818,750.00 
$3,818,750.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DANIEL 
 
BECKER 
DIRECTOR
WATCHWITH, INC.   |  NEURANA PHARMACEUTICALS, INC.   |  PRINCIPIA BIOPHARMA INC.   |  PANDION THERAPEUTICS HOLDCO LLC   |  DTX PHARMA, INC.   |  DAY ONE BIOPHARMACEUTICALS HOLDING CO LLC   |  MATCHPOINT THERAPEUTICS INC.   |  ARETEIA THERAPEUTICS, INC.
JUDY 
 
CARON 
EXECUTIVE OFFICER
NEURANA PHARMACEUTICALS, INC.
BRIAN 
 
DORSEY 
DIRECTOR
MAGNASCI FUND L.P.   |  APRICUS BIOSCIENCES, INC.   |  NEURANA PHARMACEUTICALS, INC.   |  SORRISO PHARMACEUTICALS, INC.   |  FORWARD SCIENCE HOLDING INC.
DAVID 
F. 
HALE 
DIRECTOR, EXECUTIVE OFFICER
SKINMEDICA INC   |  SOMAXON PHARMACEUTICALS, INC.   |  NEURELIS, INC.   |  RIDGE DIAGNOSTICS, INC.   |  CONATUS PHARMACEUTICALS INC   |  AGILITY CLINICAL, INC.   |  COLORESCIENCE INC   |  TOKALAS, INC.   |  RECROS MEDICA, INC.   |  IDUN PHARMACEUTICALS INC   |  MDREJUVENA, INC.   |  DERMATA THERAPEUTICS, LLC   |  ONCTERNAL THERAPEUTICS, INC.   |  ADIGICA HEALTH, INC.   |  NEURANA PHARMACEUTICALS, INC.   |  CLARIFY MEDICAL, INC.   |  ONCTERNAL THERAPEUTICS, INC.
DAVID 
 
KABAKOFF 
DIRECTOR
TRIUS THERAPEUTICS INC   |  ALLYLIX INC.   |  CEBIX INC   |  SOFINNOVA HEALTHQUEST PARTNERS, L.P.   |  LINEAGEN, INC   |  HERA THERAPEUTICS INC.   |  HEALTHQUEST PARTNERS II, L.P.   |  NEXTCURE, INC.   |  BIOTHERANOSTICS, INC.   |  DAUNTLESS 1, INC.   |  DAUNTLESS 2, INC.   |  ANTIVA BIOSCIENCES, INC.   |  BIOCLIN THERAPEUTICS, INC.   |  NEURANA PHARMACEUTICALS, INC.   |  RAINIER THERAPEUTICS, INC.   |  RARECYTE, INC.
RANDALL 
 
KAYE, M.D. 
EXECUTIVE OFFICER
NEURANA PHARMACEUTICALS, INC.
JEFFREY 
 
RASER 
EXECUTIVE OFFICER, DIRECTOR
NEURANA PHARMACEUTICALS, INC.
JOSHUA 
 
RICHARDSON 
DIRECTOR
NEURANA PHARMACEUTICALS, INC.
KATHLEEN 
D. 
SCOTT 
EXECUTIVE OFFICER
RECROS MEDICA, INC.   |  MDREJUVENA, INC.   |  ADIGICA HEALTH, INC.   |  NEURANA PHARMACEUTICALS, INC.
CRAIG 
 
THOMPSON 
DIRECTOR, EXECUTIVE OFFICER
TRINITY STREET COMMINGLED GLOBAL EQUITY FUND, LP   |  TRINITY STREET COMMINGLED EAFE EQUITY FUND, LP   |  NEURANA PHARMACEUTICALS, INC.
ALEX 
 
ZISSON 
DIRECTOR
ZOGENIX INC   |  QUINNOVA PHARMACEUTICALS, INC.   |  TRANZYME INC   |  CELATOR PHARMACEUTICALS INC   |  SBT HOLDINGS INC.   |  NEURANA PHARMACEUTICALS, INC.   |  CLICK THERAPEUTICS, INC.   |  CLARUS THERAPEUTICS HOLDINGS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-02-26
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-03 
2018-05-14
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-12-30 
2018-05-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-03 
2017-03-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-12-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#